trial · primary record
JNJ-77242113
Plaque Psoriasis
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 311 |
| Primary completion | 2027-02-17 |
| Primary endpoint | Percentage of Participants Who Achieved an Investigator's Global Assessment (IGA) Score of 0 or 1 and a Greater Than or Equal to (>=) 2-Grade Improvement From Baseline at Week 16 |
| Registry ID | NCT06095102 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:54.806Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06095102
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Jnj-77242113 · compound